Denali Therapeutics Inc. (DNLI) Secures FDA Priority Review for First-Ever Brain-Penetrant Hunter Syndrome Therapy
Denali Therapeutics Inc.
Denali Therapeutics Inc. (DNLI)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Baker Bros. Advisors Julian Baker And Felix Baker | 3,731,695 | $52,206,413 | 0.51% | |
| 2. | Point72 Asset Management Steve Cohen | 2,213,947 | $30,973,116 | 0.06% | |
| 3. | Fisher Asset Management Ken Fisher | 1,515,991 | $21,208,712 | +12% | 0.01% |
| 4. | Marshall Wace LLP Paul Marshall And Ian Wace | 1,405,250 | $19,659,447 | -36% | 0.02% |
| 5. | Citadel Investment Group Ken Griffin | 1,248,953 | $17,472,852 | +7% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $18.00 | 275,000 | $4,950,000.00 | 19,462,499 | 2017-12-12 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $13.58 | 2,937 | $39,884.46 | 242,346 | 2025-08-12 | Filing | |
| $14.64 | 806 | $11,799.84 | 216,585 | 2025-08-13 | Filing | |
| $13.58 | 2,937 | $39,884.46 | 217,391 | 2025-08-12 | Filing | |
| $15.00 | 495,282 | $7,429,230.00 | 253,071 | 2025-07-09 | Filing | |
| $20.81 | 2,907 | $60,494.67 | 175,673 | 2025-01-07 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 65,000 | $943,800 | 0.18% | |
| 2. | 23,805 | $345,649 | 0% | |
| 3. | 1,500 | $21,780 | 0% | |
| 4. | 729 | $10,585 | 0% | |
| 5. | 74 | $1,074 | 0% |
News See All
11 Best Future Stocks to Buy Now
Over the past year, investors have poured money into cutting-edge technologies like artificial intelligence and electric cars.
12 Oversold NASDAQ Stocks to Buy Now
On July 14, Max Kettner, chief multi-asset strategist at HSBC, appeared on CNBC to talk about the global markets amid trade tensions.
11 Best Gene Therapy Stocks to Buy According to Analysts
Gene therapy is a medical approach that entails changing or modifying genes to treat or prevent disease.
Jeff Bezos Investments in 2025: 12 Companies Bezos Is Investing In
Since leaving his position as CEO of Amazon in 2021, Jeff Bezos has been quite active.
12 Biotech Stocks with the Biggest Upside Potential
While 2024 was a "challenging" year for biotech stocks, JPMorgan is of the view that some names in the industry may be poised for considerable upside in the coming months.
8 Stocks Jeff Bezos is Buying
Jeff Bezos is a name closely tied to Amazon the company he reportedly founded in 1994 during a cross-country road trip.
40 Cities with the Lowest Life Expectancy in the US
In this article, we look at 40 cities with the lowest life expectancy in the US.
40 Cities with the Highest Life Expectancy in the US
In this article, we look at 40 Cities With The Highest Life Expectancy In The US.
5 Most Promising Biotech Stocks to Buy According to Analysts
In this article, we will take a look at the 5 most promising biotech stocks to buy according to analysts.
Hedge Fund Resource Center Billionaire Hedge Funds
